Phenotypic and Functional Dysregulated Blood NK Cells in Colorectal Cancer Patients Can Be Activated by Cetuximab Plus IL-2 or IL-15

The clinical outcome of colorectal cancer (CRC) is associated with the immune response; thus, these tumors could be responsive to different immune therapy approaches. Natural killer (NK) cells are key antitumor primary effectors that can eliminate CRC cells without prior immunization. We previously...

Descripción completa

Detalles Bibliográficos
Autores principales: Rocca, Yamila Sol, Roberti, María Paula, Juliá, Estefanía Paula, Pampena, María Betina, Bruno, Luisina, Rivero, Sergio, Huertas, Eduardo, Sánchez Loria, Fernando, Pairola, Alejandro, Caignard, Anne, Mordoh, José, Levy, Estrella Mariel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5056190/
https://www.ncbi.nlm.nih.gov/pubmed/27777574
http://dx.doi.org/10.3389/fimmu.2016.00413

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5056190/
https://www.ncbi.nlm.nih.gov/pubmed/27777574
http://dx.doi.org/10.3389/fimmu.2016.00413

Ejemplares similares